Vaccinex Announces Licensing of Anti-CCR8 Antibody to Surface Oncology

NEXT STORY
Adamis Pharmaceuticals Cleared to Proceed with Human Studies of Tempol for the Treatment of COVID-19
PREV STORY
Gene Panel Market Is Estimated to Reach USD 4.34 Billion by 2025 at CAGR of 12.16% | Market Research Future (MRFR)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Apellis Reports Analysis from Phase 1b Geographic Atrophy Study

author_avatar
NASDAQ Market News

Esperion Announces Two Data Presentations of NEXLETOL® (bempedoic acid) Tablet at the ESC Congress 2020

author_avatar
NASDAQ Market News

Genetron Health Enters Exclusive Global Licensing Agreement with ImmuQuad Biotechnologies to Develop and Commercialize Minimal Residual Disease Assays in Hematologic Cancer

author_avatar
NASDAQ Market News